How to Advance Research, Education, and Training in the Study of Rare Diseases
- PMID: 31401141
- PMCID: PMC8034804
- DOI: 10.1053/j.gastro.2019.08.010
How to Advance Research, Education, and Training in the Study of Rare Diseases
Conflict of interest statement
Conflicts of interest
The authors have made the following disclosures: SCG and RGS have no conflicts to disclose. ESD has received research funding from Adare, Allakos, GSK, Meritage, Miraca, Nutricia, Celgene/Receptos, Regeneron, and Shire; is a consultant for Adare, Alivio, Allakos, AstraZeneca, Banner, Biorasi, Calypso, Celgene/Receptos, Enumeral, EsoCap, Gossamer Bio, GSK, Regeneron, Robarts, Salix, and Shire; and has received educational grants from Allakos, Banner, and Holoclara. SKG is a Consultant for Abbott, Adare, Allakos, Celgene, Gossamer Bio, QOL, and UpToDate; and has received research funding from Shire.
Figures
References
-
- Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy 2015;119:964–979. - PubMed
-
- Picoraro JA, Gupta SK. Rare diseases enrich our field. AGA Perspectives. April 2019. Available from: http://agaperspectives.gastro.org/rare-diseases-enrich-our-field/#.XV70r.... Accessed August 22, 2019.
-
- Consortium of Eosinophilic Gastrointestinal Disease Researchers. Education videos. Available: www.rarediseasesnetwork.org/cms/cegir/Learn-More/Educational-Videos. Accessed August 22, 2019.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
